Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut
- PMID: 23272264
- PMCID: PMC3521651
- DOI: 10.1371/journal.pntd.0001958
Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut
Abstract
Background: Trypanosoma cruzi is the etiological agent of Chagas' disease. Cysteine peptidases are relevant to several aspects of the T. cruzi life cycle and are implicated in parasite-mammalian host relationships. However, little is known about the factors that contribute to the parasite-insect host interaction.
Methodology/principal findings: Here, we have investigated whether cruzipain could be involved in the interaction of T. cruzi with the invertebrate host. We analyzed the effect of treatment of T. cruzi epimastigotes with anti-cruzipain antibodies or with a panel of cysteine peptidase inhibitors (cystatin, antipain, E-64, leupeptin, iodocetamide or CA-074-OMe) on parasite adhesion to Rhodnius prolixus posterior midgut ex vivo. All treatments, with the exception of CA074-OMe, significantly decreased parasite adhesion to R. prolixus midgut. Cystatin presented a dose-dependent reduction on the adhesion. Comparison of the adhesion rate among several T. cruzi isolates revealed that the G isolate, which naturally possesses low levels of active cruzipain, adhered to a lesser extent in comparison to Dm28c, Y and CL Brener isolates. Transgenic epimastigotes overexpressing an endogenous cruzipain inhibitor (pCHAG), chagasin, and that have reduced levels of active cruzipain adhered to the insect gut 73% less than the wild-type parasites. The adhesion of pCHAG parasites was partially restored by the addition of exogenous cruzipain. In vivo colonization experiments revealed low levels of pCHAG parasites in comparison to wild-type. Parasites isolated after passage in the insect presented a drastic enhancement in the expression of surface cruzipain.
Conclusions/significance: These data highlight, for the first time, that cruzipain contributes to the interaction of T. cruzi with the insect host.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Coura JR, Viñas PA (2010) Chagas disease: a new worldwide challenge. Nature 465: S6–S7. - PubMed
-
- Drugs for Neglected Diseases initiative (2010) New agreement signed to join forces to takle Chagas disease. DNDi, Available: http://www.dndi.org/pressreleases/673-new-agreement-to-tackle-chagas-dis.... Accessed 2011 May 17.
-
- Azambuja P, Ratcliffe NA, Garcia ES (2005) Towards an understanding of the interactions of Trypanosoma cruzi and Trypanosoma rangeli within the reduviid insect host Rhodnius prolixus . An Acad Bras Cienc 77: 397–404. - PubMed
-
- Souto-Padrón T, Campetella OE, Cazzulo JJ, de Souza W (1990) Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction. J Cell Sci 96: 485–90. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources